{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:37:31Z","timestamp":1792762651631,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04306-8","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:51:48Z","timestamp":1779454308000},"page":"5190-5202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Profiling peripheral MDSCs and Tregs in breast cancer: clinical significance and prediction of lymph node metastasis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8020-5683","authenticated-orcid":false,"given":"Chao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziteng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhe","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"4306_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"key":"4306_CR2","doi-asserted-by":"publisher","unstructured":"Akram M, Iqbal M, Daniyal M, Khan AU. Awareness and current knowledge of breast cancer. Biol Res. 2017;50(1):33.\u00a0https:\/\/doi.org\/10.1186\/s40659-017-0140-9","DOI":"10.1186\/s40659-017-0140-9"},{"key":"4306_CR3","doi-asserted-by":"publisher","unstructured":"Cardoso F, Paluch-Shimon S, Senkus E, Curigliano G, Aapro MS, Andr\u00e9 F, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol. 2020;31(12):1623\u201349.\u00a0https:\/\/doi.org\/10.1016\/j.annonc.2020.09.010","DOI":"10.1016\/j.annonc.2020.09.010"},{"key":"4306_CR4","doi-asserted-by":"publisher","unstructured":"Xu W, Zhang T, Zhu Z, Yang Y. The association between immune cells and breast cancer: insights from Mendelian randomization and meta-analysis. Intern J of surg (London, England). 2025;111(1):230\u201341.\u00a0https:\/\/doi.org\/10.1097\/JS9.0000000000001840","DOI":"10.1097\/JS9.0000000000001840"},{"key":"4306_CR5","doi-asserted-by":"publisher","unstructured":"Barnaba V. T Cell Memory in Infection, Cancer, and Autoimmunity. Front Immunol. 2021;12:811968.sfgs.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2021.811968","DOI":"10.3389\/fimmu.2021.811968"},{"key":"4306_CR6","doi-asserted-by":"publisher","unstructured":"Lasser SA, Ozbay Kurt FG, Arkhypov I, Utikal J, Umansky V. Myeloid-derived suppressor cells in cancer and cancer therapy. Nat Rev Clin Oncol. 2024;21(2):147\u201364.\u00a0https:\/\/doi.org\/10.1038\/s41571-023-00846-y","DOI":"10.1038\/s41571-023-00846-y"},{"key":"4306_CR7","doi-asserted-by":"publisher","unstructured":"Liu JL, Xu X, Rixiati Y, Wang CY, Ni HL, Chen WS, et al. Dysfunctional circadian clock accelerates cancer metastasis by intestinal microbiota triggering accumulation of myeloid-derived suppressor cells. Cell Metab. 2024;36(6):1320-1334.e9.\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2024.04.019","DOI":"10.1016\/j.cmet.2024.04.019"},{"key":"4306_CR8","doi-asserted-by":"publisher","unstructured":"Xu Q, Lin A, Jiang A, Chen L, Zhu L, Mou W, et al. Circadian rhythms as a modulator of gut microbiota-tumor microenvironment crosstalk. Cell Mol Life Sci. 2025;82(1):409. https:\/\/doi.org\/10.1007\/s00018-025-05935-y","DOI":"10.1007\/s00018-025-05935-y"},{"key":"4306_CR9","doi-asserted-by":"publisher","unstructured":"Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7(1):12150. https:\/\/doi.org\/10.1038\/ncomms12150","DOI":"10.1038\/ncomms12150"},{"key":"4306_CR10","doi-asserted-by":"publisher","unstructured":"Pan PY, Ma G, Weber KJ, Ozao-Choy J, Wang G, Yin B, et al. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 2010;70(1):99\u2013108.\u00a0https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1882","DOI":"10.1158\/0008-5472.CAN-09-1882"},{"key":"4306_CR11","doi-asserted-by":"publisher","unstructured":"Leylek R, Alcantara-Hernandez M, Granja JM, Chavez M, Perez K, Diaz OR, et al. Chromatin Landscape Underpinning Human Dendritic Cell Heterogeneity. Cell Rep. 2020;32(12):108180.\u00a0https:\/\/doi.org\/10.1016\/j.celrep.2020.108180","DOI":"10.1016\/j.celrep.2020.108180"},{"key":"4306_CR12","doi-asserted-by":"publisher","unstructured":"Zhou L, Velegraki M, Wang Y, Mandula JK, Chang Y, Liu W, et al. Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy. J Clin Invest. 2024.\u00a0https:\/\/doi.org\/10.1172\/JCI180080","DOI":"10.1172\/JCI180080"},{"key":"4306_CR13","doi-asserted-by":"publisher","unstructured":"Khan ANH, Emmons TR, Wong JT, Alqassim E, Singel KL, Mark J, et al. Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils. Cancer Immunol Res. 2020;8(6):819\u201328.\u00a0https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0556","DOI":"10.1158\/2326-6066.CIR-19-0556"},{"key":"4306_CR14","doi-asserted-by":"publisher","unstructured":"Sun HL, Zhou X, Xue YF, Wang K, Shen YF, Mao JJ, et al. Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma. World J Gastroenterol. 2012;18(25):3303\u20139.\u00a0https:\/\/doi.org\/10.3748\/wjg.v18.i25.3303","DOI":"10.3748\/wjg.v18.i25.3303"},{"key":"4306_CR15","doi-asserted-by":"publisher","unstructured":"Khaled YS, Ammori BJ, Elkord E. Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients. J Immunol Res. 2014;2014:879897.\u00a0https:\/\/doi.org\/10.1155\/2014\/879897","DOI":"10.1155\/2014\/879897"},{"key":"4306_CR16","doi-asserted-by":"crossref","unstructured":"Zarobkiewicz M, Kowalska W, Chocholska S, Tomczak W, Szyma\u0144ska A, Morawska I, et al. High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia. Cancers (Basel). 2020;12(9):2614 (in Chinese).","DOI":"10.3390\/cancers12092614"},{"key":"4306_CR17","unstructured":"Xu XS, Long F, Jiang J. Expression concentration of myeloid-derived suppressor cells in peripheral blood of tumor-bearing females with breast cancer and the significance analysis. Chin J Med Guide. 2017;19(10):993\u20136 (In Chinese)."},{"key":"4306_CR18","doi-asserted-by":"publisher","unstructured":"Safarzadeh E, Hashemzadeh S, Duijf PHG, Mansoori B, Khaze V, Mohammadi A, et al. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer. J Cell Physiol. 2019;234(4):3515\u201325.\u00a0https:\/\/doi.org\/10.1002\/jcp.26896","DOI":"10.1002\/jcp.26896"},{"key":"4306_CR19","doi-asserted-by":"publisher","unstructured":"Yin B, Cai Y, Chen L, Li Z, Li X. Immunosuppressive MDSC and Treg signatures predict prognosis and therapeutic response in glioma. Int Immunopharmacol. 2024;141:112922.\u00a0https:\/\/doi.org\/10.1016\/j.intimp.2024.112922","DOI":"10.1016\/j.intimp.2024.112922"},{"key":"4306_CR20","doi-asserted-by":"publisher","unstructured":"Gonda K, Shibata M, Ohtake T, Matsumoto Y, Tachibana K, Abe N, et al. Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer. Oncol Lett. 2017;14(2):1766.\u00a0https:\/\/doi.org\/10.3892\/ol.2017.6305","DOI":"10.3892\/ol.2017.6305"},{"key":"4306_CR21","doi-asserted-by":"publisher","unstructured":"Li L, Chao QG, Ping LZ, Xue C, Xia ZY, Qian D, et al. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC. Cancer Biother Radiopharm. 2009;24(3):357\u201367.\u00a0https:\/\/doi.org\/10.1089\/cbr.2008.0612","DOI":"10.1089\/cbr.2008.0612"},{"key":"4306_CR22","unstructured":"Ling KL, Pratap SE, Bates GJ, Singh B, Mortensen NJ, George BD, et al. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun. 2007;7:7."},{"key":"4306_CR23","doi-asserted-by":"publisher","unstructured":"Palaz\u00f3n-Carri\u00f3n N, Jim\u00e9nez-Cortegana C, S\u00e1nchez-Le\u00f3n ML, Henao-Carrasco F, Nogales-Fern\u00e1ndez E, Chiesa M, et al. Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer. Sci Rep. 2021;11(1):14426.\u00a0https:\/\/doi.org\/10.1038\/s41598-021-93838-w","DOI":"10.1038\/s41598-021-93838-w"},{"key":"4306_CR24","unstructured":"Shen S, Liu K. Analysis of regulatory T cells and T lymphocyte subsets in peripheral blood of patients with breast tumor and their clinical significance. Chin J Reprod Health. 2024;35(3):287\u201391 (in Chinese)."},{"key":"4306_CR25","doi-asserted-by":"publisher","unstructured":"Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol. 2006;24(34):5373\u201380.\u00a0https:\/\/doi.org\/10.1200\/JCO.2006.05.9584","DOI":"10.1200\/JCO.2006.05.9584"},{"key":"4306_CR26","unstructured":"Ying X, Yuanfu Q, Diji L. Evaluation value of peripheral blood regulatory T cells and CD4+ T cells in clinical staging and prognosis of invasive breast cancer. Lingnan J Emerg Med. 2021;26(5):507\u201310 (in Chinese)."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04306-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04306-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04306-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:39:01Z","timestamp":1792759141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04306-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["4306"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04306-8","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethnics Committee of the Fourth Hospital of Hebei Medical University (Approval Number: 2017016).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}